Related Experiment Video
Updated: Jul 18, 2025

Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
Breast Milk Conferred Immunity to Infants Against COVID-19
Riya Mary Richard1, Giorgi Maziashvili2, Mai Tran3
1Faculty of Medicine, Ivane Javakhishvili Tbilisi State University, Tbilisi, GEO.
Insights
Breastfeeding offers newborns protection against respiratory infections, with breast milk containing antibodies that can shield infants from COVID-19. Evidence supports the safety and benefits of breastfeeding during the pandemic.
Area of Science:
- Immunology
- Public Health
- Neonatal Care
Background:
- Coronavirus disease 2019 (COVID-19) significantly impacted global health systems.
- Pregnant and breastfeeding women were initially excluded from COVID-19 vaccine trials, creating a gap in evidence-based recommendations.
- Breastfeeding presents potential protective benefits for newborns during the COVID-19 pandemic.
Purpose of the Study:
- To review the role of breastfeeding as a defense mechanism against COVID-19 in newborns.
- To summarize the immunological components in breast milk and their protective effects.
- To assess the safety and benefits of breastfeeding during the pandemic.
Main Methods:
- Literature review of studies on breastfeeding, breast milk composition, and infant immunity.
- Analysis of research on antibody transfer from mother to infant via breast milk.
- Evaluation of reported SARS-CoV-2 detection in breast milk and transmission risks.
Main Results:
- Human breast milk contains immunoglobulins (IgA, IgG, IgM), lactoferrin, and cells crucial for newborn protection against respiratory infections.
- Breastfeeding can reduce the incidence and severity of respiratory infections in infants, particularly in the first six months.
- Mothers who recovered from COVID-19 or were vaccinated transmitted protective antibodies to their infants through breast milk.
- While SARS-CoV-2 RNA has been detected in breast milk, the virus has not been successfully cultured, indicating a low transmission risk.
Conclusions:
- Breast milk provides significant immunological benefits, enhancing mucosal immunity and promoting a healthy microbiome in infants.
- Current evidence supports the safety and benefits of breastfeeding for infants during the COVID-19 pandemic.
- Promoting breastfeeding, with appropriate safety measures, contributes to infant health and well-being amidst the pandemic.
Abstract:
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has notably impacted healthcare systems and everyday life worldwide. Regulatory authorities have approved the emergency use of SARS-CoV-2 vaccines due to the rapid spread of the virus. However, during vaccination testing, pregnant and breastfeeding women were initially excluded, leading to a lack of evidence-based recommendations. When taking the COVID-19 pandemic into account, breastfeeding has emerged as a potential defense mechanism against this infection due to its numerous benefits for newborns. Human breast milk contains immunoglobulins (IgA, IgG, and IgM), lactoferrin, and various cells that play an inevitable role in the newborn's protection against respiratory infections and immune system development. Various studies have highlighted that the onset and severity of respiratory infections in infants can be reduced through breastfeeding, and the effects are noticeable during the first six months of life and that breast milk also has the potential to enhance mucosal immunity and promote a diverse microbiome, reducing the risk of asthma, allergies, and enteric diseases through the provision of specific antibodies and immunological factors. Researchers have indicated that breastfeeding mothers who contracted and recovered from COVID-19 or received vaccination passed protective antibodies to their infants through breast milk. Although rare cases of detection of SARS-CoV-2 RNA in breast milk have been reported, the virus has not been cultured from these samples, suggesting a low risk of transmission to the breastfed baby. However, further research is essential to understand the extent of protection provided by breast milk against COVID-19 and the potential effect of distinct phases of lactation. Nonetheless, the current evidence supports the benefits and safety of breastfeeding during the pandemic. With appropriate safety measures, promoting breastfeeding can contribute to the overall health and well-being of infants during the phase of COVID-19.
More Related Videos
04:16Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
Published on: February 7, 2025
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Microorganisms in Medicine and Therapeutics